Literature DB >> 11237239

Therapeutic apheresis.

J P Isbister1.   

Abstract

During the last 30 years in vivo blood cell separation, generally referred to apheresis, has established a central role in both blood donor programmes and therapeutics. The technological advances in apheresis equipment has made procedures safer, faster and more effective. This article will review the use of apheresis in clinical medicine with emphasis on plasma exchange and peripheral blood stem cell collection. Plasma exchange now has a pivotal role in the management of a range of disorders, specially those with autoimmune pathogenesis. However, Plasma exchange should be practised as one component of an integrated and frequently multidisciplinary approach to management. The harvesting of allogeneic or autologous of peripheral blood haemopoietic stem cells is increased and it has become the principle indication for apheresis in many haematology units. A well coordinated protocol approach to this procedure is important if adequate haemopoietic stems cells are to be collected and safely cyropreserved. This requires successful cooperation between medical, nursing and scientific personnel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237239     DOI: 10.1007/bf02728865

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  17 in total

Review 1.  Therapeutic plasma exchange and cytapheresis in pediatric patients.

Authors:  J B Gorlin
Journal:  Transfus Sci       Date:  1999-08

Review 2.  Therapeutic pediatric apheresis.

Authors:  H C Kim
Journal:  J Clin Apher       Date:  2000       Impact factor: 2.821

3.  Automated erythrocytapheresis in the treatment of severe falciparum malaria.

Authors:  D C Macallan; M Pocock; E Bishop; D H Bevan; J Parker-Williams; T Harrison; G T Robinson
Journal:  J Infect       Date:  1999-11       Impact factor: 6.072

Review 4.  Management of thrombotic thrombocytopenic purpura.

Authors:  G A Rock
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

Review 5.  Clinical pharmacokinetics during plasma exchange.

Authors:  F Fauvelle; O Petitjean; M Tod; L Guillevin
Journal:  Therapie       Date:  2000 Mar-Apr       Impact factor: 2.070

Review 6.  Recent advances of therapeutic apheresis in Guillain-Barré syndrome.

Authors:  W F Haupt
Journal:  Ther Apher       Date:  2000-08

Review 7.  Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).

Authors:  E Kakishita
Journal:  Int J Hematol       Date:  2000-06       Impact factor: 2.490

8.  Treatment of FSGS with plasma exchange and immunadsorption.

Authors:  D Franke; M Zimmering; N Wolfish; J H Ehrich; G Filler
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

Review 9.  Peripheral blood stem cell collection: the interaction of technology, procedure, and biological factors.

Authors:  J Hester
Journal:  Transfus Sci       Date:  2000-10

10.  Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis.

Authors:  R L Comenzo; E Vosburgh; L R Weintraub; S Tansan; C F Arkin; D G Wright
Journal:  Transfusion       Date:  1995-06       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.